CIK 0001662579
- Non-accelerated filer
- Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475617627
- Phone
- +1 617-231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $122,487
- in 1 filing, $122K under 10b5-1 plans
Net −$122,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-16 | Fisher Stewart Chief Scientific Officer | Exercise or conversion | +2,250 | 131,371 | ||
| 2024-09-16 | Fisher Stewart Chief Scientific Officer | Shares withheld for taxes | −661 | $6.36 | $4K | 130,710 |
| 2024-09-16 | Fisher Stewart Chief Scientific Officer | Exercise or conversion · Performance Restricted Stock Units | −2,250 | 14,250 | ||
| 2024-03-07 | Fisher Stewart Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −94,950 | 0 | ||
| 2024-03-07 | Fisher Stewart Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +94,950 | 94,950 | ||
| 2024-03-07 | Fisher Stewart Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −118,000 | 0 | ||
| 2024-03-07 | Fisher Stewart Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +118,000 | 118,000 | ||
| 2024-02-14 | Fisher Stewart Chief Scientific Officer | Grant or award | +27,300 | 129,121 | ||
| 2024-02-14 | Fisher Stewart Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +122,800 | 122,800 | ||
| 2024-02-13 | Fisher Stewart Chief Scientific Officer | Shares withheld for taxes | −2,255 | $6.53 | $15K | 101,821 |
| 2023-09-18 | Fisher Stewart Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2023-08-30 | Fisher Stewart Chief Scientific Officer | Exercise or conversion | +2,250 | 104,737 | ||
| 2023-08-30 | Fisher Stewart Chief Scientific Officer | Shares withheld for taxes | −661 | $2.93 | $2K | 104,076 |
| 2023-08-30 | Fisher Stewart Chief Scientific Officer | Exercise or conversion · Performance Restricted Stock Units | −2,250 | 16,500 | ||
| 2023-02-13 | Fisher Stewart Chief Scientific Officer | Grant or award | +26,000 | 102,487 | ||
| 2023-02-13 | Fisher Stewart Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-01-30 | Fisher Stewart Chief Scientific Officer | Exercise or conversion | +3,750 | 77,788 | ||
| 2023-01-30 | Fisher Stewart Chief Scientific Officer | Shares withheld for taxes | −1,301 | $7.78 | $10K | 76,487 |
| 2023-01-30 | Fisher Stewart Chief Scientific Officer | Exercise or conversion · Performance Restricted Stock Units | −3,750 | 18,750 | ||
| 2022-05-26 | Fisher Stewart Chief Scientific Officer | Shares withheld for taxes | −1,102 | $7.01 | $8K | 74,038 |
Page 1 of 3 · 46 trades